11/30/2022 | BK | Market Commentary: Horizon Pharma up on possible buyout; Cubic slides with downgrades; Sebia finalizes terms
|
12/17/2018 | BKCVHY | Moody's lowers Horizon view to stable
|
10/19/2018 | BK | Market Commentary: Juice Plus+, Cision break; SAIC, Wynn, Peninsula, Pixelle, Custom Truck, Jacobs updated
|
10/17/2018 | BK | Market Commentary: Welbilt, BroadStreet, CPA, Consilio, Park Place, Horizon break; United Natural reworked
|
10/9/2018 | BK | Market Commentary: Forming Machining frees up, Dealogic tweaks deal; Paradigm, CPM, Numotion and more set talk
|
10/9/2018 | BK | Horizon Pharma launches $818 million term loan at Libor plus 300 bps
|
10/5/2018 | BK | Market Commentary: United Rentals, RevSpring, Fogo de Chao, NFP, GoodRx, J.D. Power, NEP Group, NES break
|
10/5/2018 | BK | Horizon Pharma to launch new loan deal on Tuesday afternoon
|
10/17/2017 | BK | Market Commentary: Horizon Pharma breaks; Red Ventures, Resolute Investment, Xplornet tweak loan deals
|
10/10/2017 | BK | Market Commentary: First Eagle launches $1.52 billion, UPC $1.6 billion and €500 million
|
10/10/2017 | BK | Horizon Pharma launches $845.75 million repricing of term loan B
|
5/9/2017 | BKHY | Moody’s: Horizon Pharma view to negative
|
3/23/2017 | BK | Market Commentary: Dole Food, BWAY, Horizon Pharma, Citco Funding break; Hargray, Las Vegas Sands update deals
|
3/22/2017 | BK | Market Commentary: Altice, Highline, SFR break; Horizon Pharma, BWAY update deals; Hargray, RGIS move deadlines
|
3/22/2017 | BKHY | Moody’s rates Horizon Pharma loan Ba2
|
3/22/2017 | BK | Horizon Pharma lifts term loan B to $850 million, updates pricing
|
3/14/2017 | BK | Market Commentary: Valeant, Arctic Glacier, Camping World, Navico free to trade; Horizon Pharma terms surface
|
3/14/2017 | BK | Horizon Pharma launches $769 million term B at Libor plus 375-400 bps
|
3/13/2017 | BK | Market Commentary: Contura, Aveanna, Resolute break; Cyxtera, GEO, Cole-Parmer, Kenan, Camping World revised
|
3/13/2017 | BK | Horizon Pharma readies launch of new loan deal for Tuesday morning
|
10/20/2016 | BK | Market Commentary: Warner, Horizon, Husky, Forterra, Kronos break; Serta, Suddenlink, SCA, Pro Mach revised
|
10/20/2016 | BK | Horizon Pharma sets $375 million term loan B at Libor plus 450 bps
|
10/19/2016 | BK | Market Commentary: K&N Engineering, CommScope break; Tweddle Group, Horizon Pharma deal changes surface
|
10/19/2016 | BK | Horizon Pharma changes term loan B talk to Libor plus 425-450 bps
|
10/13/2016 | BKHY | Moody’s drops Horizon Pharma debt, rates new debt
|
10/13/2016 | BKCVHY | S&P rates Horizon loan BB-, notes B-
|
12/3/2015 | BKBWCVHYLW | Horizon Pharma has 4.6x leverage, could go to 6x for right opportunity
|
5/7/2015 | BK | Market Commentary: TTM Technologies, Chemours, Leighton, Quintiles, eResearch, Black Knight free to trade
|
4/29/2015 | BK | Market Commentary: Horizon Pharma breaks; Avaya updated; Script Relief, Air Canada, Sensata, Veresen launch
|
4/24/2015 | BKCVDDEMIGPV | Market Commentary: Three-part ZF Friedrichshafen, Horizon Pharma cap $11.5 billion week, new bonds better
|
4/23/2015 | BKCVDDEMIGPV | Market Commentary: Downsized DJO issue, Trinseo deal, Virgin Media add-on price; funds lose $162.2 million
|
4/21/2015 | BKCVHY | S&P: Horizon Pharma loan BB-, notes B-, convertibles CCC+
|
4/20/2015 | BKHY | Moody’s rates Horizon Pharma loan Ba2, notes B2
|
9/19/2014 | BK | Horizon Pharma draws full $300 million under term loan for acquisition
|
6/19/2014 | BK | Horizon Pharma gets $300 million term loan for Vidara acquisition
|
3/19/2014 | BKHY | Horizon Pharma lines up $250 million five-year bridge loan for buyout
|